Quantinuum (NASDAQ:QNT) Upgraded to Strong-Buy at UBS Group

UBS Group upgraded shares of Quantinuum (NASDAQ:QNTFree Report) to a strong-buy rating in a report issued on Monday,Zacks.com reports.

A number of other research analysts also recently commented on the company. Needham & Company LLC started coverage on Quantinuum in a report on Monday. They issued a “buy” rating and a $100.00 price target for the company. Cantor Fitzgerald initiated coverage on Quantinuum in a research report on Monday. They issued an “overweight” rating and a $90.00 target price on the stock. Morgan Stanley initiated coverage on Quantinuum in a research note on Monday. They set an “equal weight” rating and a $78.00 target price for the company. Evercore started coverage on shares of Quantinuum in a research report on Monday. They set an “outperform” rating and a $98.00 price target for the company. Finally, Wall Street Zen upgraded shares of Quantinuum to a “hold” rating in a research note on Saturday, June 20th. Four investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Quantinuum presently has an average rating of “Buy” and an average price target of $98.75.

Read Our Latest Research Report on Quantinuum

Quantinuum Stock Up 12.2%

NASDAQ:QNT opened at $81.74 on Monday. Quantinuum has a fifty-two week low of $50.10 and a fifty-two week high of $82.30.

Insider Activity at Quantinuum

In other news, Director Manish H. Bhatia purchased 20,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average cost of $60.00 per share, with a total value of $1,200,000.00. Following the transaction, the director owned 25,833 shares in the company, valued at approximately $1,549,980. The trade was a 342.88% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Joseph Jimenez acquired 66,665 shares of Quantinuum stock in a transaction that occurred on Friday, June 5th. The shares were purchased at an average price of $60.00 per share, for a total transaction of $3,999,900.00. Following the completion of the purchase, the director directly owned 72,498 shares of the company’s stock, valued at $4,349,880. The trade was a 1,142.89% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 411,032 shares of company stock worth $24,661,920 over the last quarter.

Quantinuum News Summary

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Several major firms initiated or upgraded coverage on Quantinuum with upbeat ratings, including “strong-buy” calls from Cantor Fitzgerald, Evercore, and Jefferies, plus buy/overweight ratings from JPMorgan, Bank of America, Needham, Mizuho, Craig Hallum, Rosenblatt, and others. Many of these targets imply meaningful upside from recent levels.
  • Positive Sentiment: Analysts highlighted Quantinuum as a key quantum-computing name, with one report calling it a new Wall Street favorite and another noting triple-digit upside potential, reinforcing the stock’s momentum. Article Title
  • Positive Sentiment: Recent insider-buying headlines also supported sentiment, including reports of about $25 million in post-IPO insider purchases and a congressman’s disclosed purchase of Quantinuum stock, which investors may interpret as a confidence signal. Article Title
  • Positive Sentiment: Coverage linking the stock to a recent quantum-computing executive order and noting a sharp share-price move added to the momentum trade around the name. Article Title

About Quantinuum

(Get Free Report)

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.

Further Reading

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.